Corin MiniHip and Trinity Cup Clinical Surveillance Study

Active, not recruiting

• Conditions: Total Hip Arthroplasty; Osteoarthritis, Hip; Traumatic Arthritis of Hip; Avascular Necrosis of the Femoral Head; Developmental Dysplasia of the Hip; Rheumatoid Arthritis of Hip

• Registration Number: NCT05186168
• Lead Sponsor: Corin

Brief Summary

The aim of the study is to provide long term follow up data on the performance and safety of the Corin MiniHip and Trinity acetabular cup over a 10-year period.

Detailed Description

To verify the ten-year clinical and radiographic performance of the Corin MiniHip and Trinity Advanced Bearing Acetabular System when used in patients under normal conditions of use.

To document the safety, evaluate patient satisfaction, quality of life and to determine the survivorship following intervention with the Corin MiniHip and Trinity Advanced Bearing Acetabular System at each follow-up visit.

Study Timeline

• Study Start: 2011-03-15
• Study First Submitted: 2021-12-15
• Study First Submitted QC: 2022-01-06
• Study First Posted: 2022-01-11
• Status Verified: 2023-08
• Last Update Submitted: 2023-08-31
• Last Update Posted: 2023-09-01
• Primary Completion: 2028-05-03
• Study Completion: 2028-05-03

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 546

Inclusion Criteria

• A severely painful and/or disabled joint from osteoarthritis, traumatic arthritis, rheumatoid arthritis or developmental dysplasia of the hip.
• Avascular necrosis of the femoral head
• All subjects must be between the age of 18 and 75 at the time of surgery to take part in this study
• Scheduled for a primary total hip replacement.

Exclusion Criteria

• Active infection
• Severe Obesity (BMI over 35)
• Pregnancy
• Mental illness
• Grossly distorted anatomy (surgeon's discretion)
• Sepsis
• Osteomyelitis
• Osteomalacia
• Distant foci of infections
• Osteoporosis
• Metabolic disorders which may impair bone formation
• Muscular atrophy or neuromuscular disease
• Allergy to implant material
• Marked bone loss or bone resorption
• Patients without sufficient quantities of synovial fluid to allow for proper lubrication, such as patients with Sjogren's syndrome
• Skeletally immature patients and cases where there is a loss of abductor musculature, poor bone stock or poor skin coverage around the hip joint which would make the procedure inappropriate
• Any case not described in the inclusion criteria
• Any patient who cannot or will not provide informed consent for participation in the study
• Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Post operative survivorship of the Minihip Stem and Trinity acetabular Cup system at 10-year follow-up	10 years	Survivorship measured via Kaplan-Meier (KM) curve

Secondary Outcome Measures

Name	Time	Method
Minihip Stem radiographic performance up to 10-years	Baseline to 10 years	Radiographic assessment considering osteolysis and femoral stem alignment measured as Varus/Valgus and the use of the Gruen's assessment zones 1-7
Minihip Stem and Trinity acetabular cup radiographic performance up to 10-years	Baseline to 10 years	Radiographic assessment considering heterotopic ossifications using the Brooker classification Grade 1 - 4.
Oxford Hip Score (OHS) up to 10-year follow-up	Baseline to 10 years	Oxford Hip Score is a patient-centered questionnaire that is designed to assess functional ability and pain from the patient's perspective. It is a short, twelve-item questionnaire developed for completion by patients undergoing THA. Minimum score 0 indicating worst outcome, maximum score 48 indicating best outcome.
Trinity acetabular cup radiographic performance up to 10-years	Baseline to 10 years	Radiographic assessment considering Acetabular radiolucent lines using the De lee Charney measurement of zones 1 - 3.
Harris Hip Score (HHS) up to 10-year follow-up	Baseline to 10 years	Harris Hip Score is a disease-specific scoring system, originally intended as an outcome score after arthroplasty surgeries that includes the domains of function, pain, motion and deformity. Minimum score is 0, Maximum score is 100. The score is reported as 90-100 for excellent results, 80-89 for good, 70-79 for fair, 60-69 for poor, and below 60 for a failed result.
Hip- and device-related adverse events up to 10-year follow-up	Baseline to 10 years	All hip-related and device-related complications, including those occurring during the surgical procedure and throughout the postoperative evaluations, are required to be documented and reviewed